WDR11-AS1 expression is downregulated in osteoarthritic cartilage and inhibits inflammation-induced extracellular matrix (ECM) degradation by directly binding to PABPC1, highlighting its potential as a therapeutic target for osteoarthritis (93). This evidence concerns the gene WDR11 and osteoarthritis.